# The Effect of Adding Metformin to the Treatment of Hepatitis C

> **NCT00560690** · PHASE4 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 140 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Metformin
- **DRUG:** pegylated interferon
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00560690
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2015-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560690, "The Effect of Adding Metformin to the Treatment of Hepatitis C". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00560690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*